We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of tumor microenvironment. The paper list is as follows:
“Potential Pathophysiological Pathways in the Complex Relationships between OSA and Cancer”
by Manuel Sánchez-de-la-Torre, Carolina Cubillos, Olivia J. Veatch, Francisco Garcia-Rio, David Gozal and Miguel Angel Martinez-Garcia
Cancers 2023, 15(4), 1061; https://doi.org/10.3390/cancers15041061
Available online: https://www.mdpi.com/2072-6694/15/4/1061
“Optical Genome Mapping for Cytogenetic Diagnostics in AML”
by Verena Nilius-Eliliwi, Wanda M. Gerding, Roland Schroers, Huu Phuc Nguyen and Deepak B. Vangala
Cancers 2023, 15(6), 1684; https://doi.org/10.3390/cancers15061684
Available online: https://www.mdpi.com/2072-6694/15/6/1684
“Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers”
by Kellen Wright, Thuc Ly, Matthew Kriet, Andras Czirok and Sufi Mary Thomas
Cancers 2023, 15(6), 1899; https://doi.org/10.3390/cancers15061899
Available online: https://www.mdpi.com/2072-6694/15/6/1899
“Relationship between Tumor Budding and Partial Epithelial–Mesenchymal Transition in Head and Neck Cancer”
by Kohei Okuyama, Keiji Suzuki and Souichi Yanamoto
Cancers 2023, 15(4), 1111; https://doi.org/10.3390/cancers15041111
Available online: https://www.mdpi.com/2072-6694/15/4/1111
“Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the ‘NSCLC’ of GI Oncology?”
by Amol Gupta, Razelle Kurzrock and Jacob J. Adashek
Cancers 2023, 15(5), 1578; https://doi.org/10.3390/cancers15051578
Available online: https://www.mdpi.com/2072-6694/15/5/1578
“Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer”
by Samantha Gogola, Michael Rejzer, Hisham F. Bahmad, Ferial Alloush, Yumna Omarzai and Robert Poppiti
Cancers 2023, 15(5), 1621; https://doi.org/10.3390/cancers15051621
Available online: https://www.mdpi.com/2072-6694/15/5/1621
“Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma”
by Yun-Yun Tao, Yue Shi, Xue-Qin Gong, Li Li, Zu-Mao Li, Lin Yang and Xiao-Ming Zhang
Cancers 2023, 15(2), 365; https://doi.org/10.3390/cancers15020365
Available online: https://www.mdpi.com/2072-6694/15/2/365
“Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect”
by Hongyang Deng, Jiaxing Zhang, Fahong Wu, Fengxian Wei, Wei Han, Xiaodong Xu and Youcheng Zhang
Cancers 2023, 15(4), 1169; https://doi.org/10.3390/cancers15041169
Available online: https://www.mdpi.com/2072-6694/15/4/1169
“PARP Inhibitors in Breast and Ovarian Cancer”
by Samuel S. Y. Wang, Yeo Ee Jie, Sim Wey Cheng, Goh Liuh Ling and Heong Valerie Yue Ming
Cancers 2023, 15(8), 2357; https://doi.org/10.3390/cancers15082357
Available online: https://www.mdpi.com/2072-6694/15/8/2357
“Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice”
by Anna Chen, Ines Neuwirth and Dietmar Herndler-Brandstetter
Cancers 2023, 15(11), 2989; https://doi.org/10.3390/cancers15112989
Available online: https://www.mdpi.com/2072-6694/15/11/2989
You are welcome to submit relevant papers to the journal Cancers.
Cancers Editorial Office
